Valence 로고
인기
로그인
Loading data for DERM — first visit, this takes a few seconds.

관심목록에 추가

Journey Medical Corporati...

NasdaqCM: DERM · 실시간 가격 · USD
6.46
-0.26 (-3.87%)
종가 기준: Aug 19, 2026, 8:00 PM
6.81
+0.00%
애프터마켓: 4:10 PM

Journey Medical Corporation (DERM) Stock Price, Analysis & Data

-3.87%

데이터 없음

매수호가4.76
시가총액192.21M
매출 (ttm)68.18M
순이익 (ttm)-6.1M
베타1.08
EPS (ttm)-0.22
P/E (ttm)n/a
선행 P/E-113.5
P/B (ttm)5.81
P/S (ttm)2.82
Earnings DateNov 11, 2026
매도호가8.35
거래량287,622
평균 거래량 (20일)256,918
시가6.73
전일 종가6.72
일중 범위6.45 - 6.81
52주 범위4.31 - 9.55
애널리스트n/a
목표주가n/a
배당n/a
배당락일n/a

DERM 소개

Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topica...

[더 보기]
산업 Drug Manufacturers - Specialty & Generic
섹터 Healthcare
IPO 일자 Nov 12, 2021
직원 수 58
상장 거래소 NasdaqCM
티커 DERM
웹사이트 https://journeymedicalcorp.com
전체 기업 정보

재무 실적

2025년 Journey Medical의 매출은 61.86M로, 전년 56.13M 대비 10.2% 증가했습니다. 순이익은 -11.43M로, -22.09% 감소했습니다.

재무제표

어닝 서프라이즈

Journey Medical가 Aug 12, 2026에 분기 실적을 발표했습니다:
  • 매출 $15.96M 예상치 하회 $0, 및 21.48% 전년 대비 성장.
  • EPS -0.01 예상치 상회 0.01, 및 93.75% 전년 대비 성장.

    • 다음 실적 발표

    Journey Medical Corporation의 실적 발표 예정일은 Nov 11, 2026, 정규장 중입니다.
    애널리스트 예상 매출은 ... 업그레이드
    news image

    6일 전 · GuruFocus.com

    Journey Medical Corp (DERM) (Q2 2026) Earnings Call Highlights: Emrosi Surges 20% Sequentially, ...

    Journey Medical Corp (DERM) narrows net loss to $300K as Emrosi prescriptions hit all-time highs and payer access expands.

    news image

    6일 전 · Moby

    Journey Medical Corporation Q2 2026 Earnings Call Summary

    Moby summary of Journey Medical Corporation's Q2 2026 earnings call

    news image

    6일 전 · MarketBeat

    Fortress Biotech Q2 Earnings Call Highlights

    Journey Medical reported higher second-quarter revenue and improved profitability, driven by continued prescription growth and improving payer reimbursement for its rosacea treatment Emrosi. Chief Exe...

    news image

    6일 전 · MarketBeat

    Journey Medical Q2 Earnings Call Highlights

    Journey Medical (NASDAQ:DERM) reported higher second-quarter revenue and a sharply narrower net loss as sales of its rosacea treatment EMROSI continued to grow, supported by rising prescription volume...

    news image

    6일 전 · Zacks

    Here's What Key Metrics Tell Us About Journey Medical (DERM) Q2 Earnings

    The headline numbers for Journey Medical (DERM) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street e...

    2 페이지 중 1